Discovery and Pharmacological Evaluation of STEAP4 as a Novel Target for HER2 Overexpressing Breast Cancer.

Front Oncol · 2021 · PMC8034292 · PMID 33842315

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

However, no statistically significant correlations were observed between STEAP4 expression and all the other clinicopathological features, although a strong trend was evident with lymph node metastasis and a weaker one with pT status.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.